CASE 13221 Published on 09.12.2015

Cerebellar pilocytic astrocytoma: MR spectroscopy

Section

Neuroradiology

Case Type

Clinical Cases

Authors

Jitender Singh, Shaista Siddiqui, Pankaj Gupta, Mohd Khalid, Premlata

Jawarlal Nehru Medical College, Aligarh Muslim University;Aligarh Road 202001 Aligarh, India; Email:introductory2008@gmail.com
Patient

12 years, male

Categories
Area of Interest Neuroradiology brain ; Imaging Technique MR, MR-Spectroscopy, CT
Clinical History
The patient presented with a gradual onset of drowsiness and a few episodes of vomiting since one week. Clinical examination and routine hematological examination were normal.
Imaging Findings
CECT shows a solid cystic lesion in the posterior fossa with proximal triventricular hydrocephalus (Fig 1).
T1WI shows a hypointense lesion in the cerebellum in midline (Fig 2a). T2WI shows a hyperintense lesion in the posterior fossa region with an effaced 4th ventricle (Fig 2b). Post contrast T1WI shows peripheral enhancement of the cyst wall with an eccentric enhancing mural nodule (Fig 3).
On MRS the lesion shows lactate doublet at 1.3ppm with reduced Cr and NAA with elevated Cho peak (Fig 4).
Discussion
Pilocytic astrocytomas are the second overall most common form of paediatric brain tumours. Cerebellar Pilocytic astrocytoma is the most common cerebellar tumour in children [1]. Magnetic resonance (MR) imaging is used in the diagnosis and follow-up. However, conventional MR imaging does not provide information about tissue biochemistry. The peak incidence of Cerebellar Pilocytic astrocytoma is between the ages of 5 and 13 years. The WHO classifies pilocytic astrocytoma as a grade 1 tumour. There is virtually no evidence of malignant degeneration within this type of tumour.They commonly occur in the optic chiasm, hypothalamus, and optic nerves and most often are associated with the predisposing syndrome of NF1. The clinical feature is due to the mass effect on adjacent neural structure usually a result of increased intracranial tension. The cysts can be more problematic as a mass effect than the solid portion of the tumour. The solid portion of the tumour is hypodense relative to the cortex, and the cystic portion of the tumour is even more hypodense on CT. The solid portion shows contrast enhancement. On MR, typically the solid portion of these tumours is hypointense on T1 and hyperintense on FLAIR / T2. The MRS spectra of pilocytic astrocytoma revealed high Cho/NAA and Cho/Cr ratios (3.53 ± 1.5) and (7.21 ± 4.2), respectively, relative low concentrations of creatine with an increased NAA/Cr ratio (2.32 ± 1.1). Lactate doublet was detected in all cases while no lipid peaks were detected [2].
Hwang et al. found that pilocytic astrocytoma has relatively high Cho/NAA and Cho/Cr ratios, 3.4 ± 2.14 and 3.46 ± 1.46 respectively, with an elevated lactate doublet which was observed in all the studied cases. No dominant lipid peak was observed [3]. Cecil et al. stated that pilocytic astrocytomas exhibit elevated lactate, Cho and diminished levels of NAA, Cr, and mIns [4]. MRS of medulloblastoma is characterised by high choline peak. Absent or low lipid peak has also been described in medulloblastoma and is said to be useful in the differential diagnosis from metastasis or astrocytoma. Taurine peak is thought to be relatively specific for medulloblastoma. MR spectroscopy should be a part of the routine MR examination for cases with suspected pilocytic astrocytoma as it could increase the imaging diagnostic efficiency of such tumours even before surgical removal or histopathological examination.
Take home message: Pilocytic astrocytoma has a specific metabolic profile which is characterized by low creatine, elevated choline/creatine and N-acetyl aspartate/creatine ratios with the presence of lactate doublet at 1.3 ppm.
Differential Diagnosis List
CEREBELLAR PILOCYTIC ASTROCYTOMA
Cystic medulloblastoma
pilocytic xanthoastrocytoma
Final Diagnosis
CEREBELLAR PILOCYTIC ASTROCYTOMA
Case information
URL: https://www.eurorad.org/case/13221
DOI: 10.1594/EURORAD/CASE.13221
ISSN: 1563-4086
License